ImmunoPrecise Antibodies: Q2 Earnings Insights
ImmunoPrecise Antibodies: Q2 Earnings Insights
Revenue was down $136 thousand from the same period last year.The earnings results for ImmunoPrecise Antibodies (NASDAQ:IPA) for Q2 were made public on Tuesday, December 10, 2024 at 08:30 AM.
免疫精准抗体（纳斯达克：IPA）第二季度的财报于2024年12月10日星期二上午08:30发布。
Here's a comprehensive overview of the announcement.
这是公告的全面概述。
Earnings
财报
ImmunoPrecise Antibodies missed estimated earnings by -40.0%, reporting an EPS of $-0.07 versus an estimate of $-0.05.
免疫精准抗体的每股收益比预期少了40.0%，报告的每股收益为-$0.07，而预期为-$0.05。
Revenue was down $136 thousand from the same period last year.
营业收入比去年同期下降了$13.6万。
Analysis of Past Earnings
过去收益分析
Last quarter the company missed on EPS by $0.03 which was followed by a 7.000000000000001% increase in the share price the next day.
上个季度该公司的每股收益比预期少了$0.03，随后股价在第二天上涨了7.000000000000001%。
Here's a look at ImmunoPrecise Antibodies's past performance:
以下是免疫精准抗体的过往表现：
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.08 | -0.07 | -0.100 |
| EPS Actual | -0.11 | -0.58 | -0.08 | -0.074 |
| Revenue Estimate | 4.96M | 4.72M | 4.50M | 4.33M |
| Revenue Actual | 3.87M | 4.72M | 4.55M | 4.62M |
| 季度 | 2025年第一季度 | 2024年第四季度 | 2024年第三季度 | 2024年第二季度 |
|---|---|---|---|---|
| 每股收益预估值 | -0.08 | -0.08 | -0.07 | -0.100 |
| 每股收益实际值 | -0.11 | -0.58 | -0.08 | -0.074 |
| 营业收入估计 | 4.96M | 4.72M | 4.50M | 4.33M |
| 营业收入实际 | 3.87M | 4.72M | 4.55M | 4.62M |
To track all earnings releases for ImmunoPrecise Antibodies visit their earnings calendar here.
要查看ImmunoPrecise Antibodies的所有财报，请在此访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审核。